2026 Q2 Portfolio Activity
In 2026 Q2, PFIZER INC maintained a portfolio of 18 distinct positions. The fund also reduced its exposure to ORIC PHARMACEUTICALS INC by 92.2%.
Position History
hover any row below to update
Loading…
PFIZER INC
New York, NY
Public Company (Corporate Treasury / Institutional Investment Manager)
AUM $170M
Total Positions
18
Quarter
2026 Q2
Top Holding
ALLO (27.5%)
Top 10 Concentration
95.8%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-18 of 18
PFIZER INC Full Holdings List — 2026 Q2
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
ALLO
ALLOGENE THERAP...
|
Healthcare | 27.55% | 20.85% |
#1
1
Prev: #2
|
7.0 |
—
|
no change | no change |
P
S
|
22,032,040 | $46,928,245 | 2024 Q4 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
CELC
CELCUITY INC
|
Healthcare | 17.35% | 13.13% |
#2
2
Prev: #4
|
6.5 |
—
|
no change | no change |
P
S
|
295,652 | $29,550,417 | 2024 Q4 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
ARVN
ARVINAS INC
|
Healthcare | 16.24% | 14.63% |
#3
Prev: #3
|
6.0 |
—
|
no change | no change |
P
S
|
3,457,815 | $27,662,520 | 2024 Q4 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
PYXS
PYXIS ONCOLOGY ...
|
Healthcare | 11.43% | 3.86% |
#4
3
Prev: #7
|
5.5 |
—
|
no change | no change |
P
S
|
7,032,770 | $19,480,773 | 2024 Q4 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
WVE
WAVE LIFE SCIEN...
|
Healthcare | 6.42% | 5.00% |
#5
1
Prev: #6
|
4.1 |
—
|
no change | no change |
P
S
|
1,875,000 | $10,931,250 | 2024 Q4 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
BHVN
BIOHAVEN LTD
|
Healthcare | 4.70% | 1.77% |
#6
4
Prev: #10
|
2.9 |
—
|
no change | no change |
P
S
|
505,645 | $8,004,360 | 2024 Q4 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
CRBU
CARIBOU BIOSCIE...
|
Healthcare | 4.63% | 3.50% |
#7
1
Prev: #8
|
2.9 |
—
|
no change | no change |
P
S
|
4,690,431 | $7,879,924 | 2024 Q4 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
SPRO
SPERO THERAPEUT...
|
Healthcare | 3.13% | 2.31% |
#8
1
Prev: #9
|
2.3 |
—
|
no change | no change |
P
S
|
2,362,348 | $5,338,906 | 2024 Q4 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
ZNTL
ZENTALIS PHARMA...
|
Healthcare | 2.26% | 0.84% |
#9
3
Prev: #12
|
1.9 |
—
|
no change | no change |
P
S
|
953,834 | $3,853,489 | 2024 Q4 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
ORIC
ORIC PHARMACEUT...
|
Healthcare | 2.09% | 24.14% |
#10
9
Prev: #1
|
0.8 |
—
|
-4,407,497 | -92.2% |
P
S
|
372,904 | $3,553,775 | 2024 Q4 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
CRDF
CARDIFF ONCOLOG...
|
Healthcare | 1.77% | 1.57% |
#11
Prev: #11
|
1.7 |
—
|
no change | no change |
P
S
|
2,411,575 | $3,014,469 | 2024 Q4 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
ZURA
ZURA BIO LTD
|
Healthcare | 1.69% | 7.05% |
#12
7
Prev: #5
|
0.7 |
—
|
-2,300,072 | -81.0% |
P
S
|
538,841 | $2,882,799 | 2024 Q4 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
N/A
AGOMAB THERAPEU...
|
|
Unknown | 0.61% | 0.34% |
#13
1
Prev: #14
|
1.2 |
—
|
no change | no change |
P
S
|
75,000 | $1,035,750 | — | 13F Filing | 2026-06-30 | 2026-08-13 | ||
|
BOLT
BOLT BIOTHERAPE...
|
Healthcare | 0.08% | 0.06% |
#14
2
Prev: #16
|
1.0 |
—
|
no change | no change |
P
S
|
31,305 | $133,832 | 2024 Q4 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
NXTC
NEXTCURE INC
|
Healthcare | 0.04% | 0.64% |
#15
2
Prev: #13
|
0.0 |
—
|
-109,007 | -71.1% |
P
S
|
44,347 | $72,967 | 2024 Q4 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
DNA
GINKGO BIOWORKS...
|
Healthcare | 0.02% | 0.01% |
#16
1
Prev: #17
|
1.0 |
—
|
no change | no change |
P
S
|
2,928 | $30,012 | 2024 Q4 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
SENS
SENSEONICS HLDG...
|
Healthcare | 0.01% | 0.01% |
#17
1
Prev: #18
|
1.0 |
—
|
no change | no change |
P
S
|
2,171 | $12,418 | 2024 Q4 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
QTTB
Q32 BIO INC
|
Healthcare | 0.00% | 0.31% |
Sold All 😨
(Was: #15) |
0.0 |
—
|
-101,618 | -100.0% |
CLOSED
|
— | $— | 2024 Q4 | 13F Filing | 2026-06-30 | 2026-08-13 |
Showing 1-18 of 18 holdings